Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

Safety of Levemir® (Insulin Detemir) Treatment in Children and Adolescents With Type 1 Diabetes (PREDICTIVE™ - Youth)

This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during Levemir® treatment.

Inclusion Criteria:

• Informed consent obtained prior to any trial-related activities
• Any patient with diabetes type 1 is eligible for the study, including newly
• The selection of the patients will be at the discretion of the individual physician

Exclusion Criteria:

• Type 2 diabetes
• Currently treated with Levemir®